HIGHLIGHTS
- who: Robert L. Murphy from the Fakir Mohan University, India have published the paper: The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials, in the Journal: (JOURNAL)
- what: This trial demonstrated favourable safety profiles with a broad and potent induction of T_cell responses independent of the variant of concern (VoC) status. phase II trials evaluating T_cell vaccines in B cell or antibody deficient patients are ongoing.
SUMMARY
Route of vaccine entry is also an important consideration, as direct stimulation of mucosal cell-mediated immunity may . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.